Brain Health
Phase 1 Trial Maps How NR and NMN Reach the Brain After Supplementation
A completed pharmacokinetic study tracks NAD precursors NR and NMN from bloodstream to brain, filling a critical gap in human data.
Clinical Trial
May 12, 2026 0
Results for "GlyNAC Supplementation" in Alzheimer's
20 articles
Brain Health
Carnosine Supplement Targets Neuromuscular Decline in Multiple Sclerosis
A completed pilot trial tests whether 2g/day of a novel carnosine formulation can restore neuromuscular function and quality of life in MS patients.
Clinical Trial
Jun 17, 2026 0
Brain Health
New Drug Shows Promise in Preventing Alzheimer's Amyloid Buildup in Young Adults
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
Clinical Trial
Mar 28, 2026 0
Brain Health
Nordic Berries Put to the Test for Fighting Age-Related Cognitive Decline
A completed trial tests whether daily Nordic berry beverages can sharpen cognition in healthy adults over 12 weeks.
Clinical Trial
Jun 14, 2026 0
Brain Health
Creatine Monohydrate Tested as Bioenergetic Therapy for Alzheimer's Disease
A completed University of Kansas trial investigates whether creatine monohydrate can support brain energy metabolism in Alzheimer's patients.
Clinical Trial
Jun 18, 2026 0
Brain Health
Drugs That Boost Brain Waste Clearance During Sleep Show Promise Against Alzheimer's
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
Clinical Trial
May 16, 2026 0
Brain Health
Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
Clinical Trial
Mar 28, 2026 2
Brain Health
Gamma Interferon Pilot Trial Tests Frataxin Boost in Friedreich Ataxia Patients
A Phase 2 open-label trial explores whether an approved immune drug can raise frataxin protein levels and slow neurological decline in Friedreich Ataxia.
Clinical Trial
Jun 16, 2026 0
Brain Health
Alpha-Lipoic Acid Added to Flunarizine Tested for Teen Migraine Prevention
A completed Phase 4 trial from India evaluates whether ALA supplementation boosts flunarizine's migraine-prevention power in adolescents.
Clinical Trial
Jun 17, 2026 0
Brain Health
New Device Aims to Measure Brain's Waste-Clearing System During Sleep
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
Clinical Trial
May 16, 2026 0
Brain Health
Chewing Gum and Intermittent Fasting May Boost Brain Health in Aging Adults
King's College study tests whether simple chewing and fasting patterns can enhance cognitive function and neurogenesis in older adults.
Clinical Trial
Mar 29, 2026 1
Brain Health
Microalgae Supplement BrainPhyt Shows Promise for Cognitive Health in Older Adults
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
Clinical Trial
Mar 28, 2026 0
Brain Health
Fish Oil and Alpha Lipoic Acid Show Promise Against Alzheimer's Disease Progression
Small trial tested whether fish oil and alpha lipoic acid could slow Alzheimer's by reducing oxidative stress markers in blood.
Clinical Trial
Mar 28, 2026 1
Brain Health
Rapastinel Shows Lower Abuse Potential Than Ketamine in Phase 1 Trial
A completed Phase 1 trial compared the abuse liability of rapastinel versus ketamine in recreational polydrug users, with implications for safer depression treatment.
Clinical Trial
Jun 5, 2026 0
Brain Health
Liraglutide Shows Promise for Protecting Cognitive Function in Type 2 Diabetes
A Phase 3 trial investigates whether the GLP-1 drug liraglutide can slow cognitive decline in T2DM patients at elevated Alzheimer's risk.
Clinical Trial
May 20, 2026 0
Brain Health
Green Tea Extract Plus Lifestyle Changes Tested Against Cognitive Decline in High-Risk Adults
A completed trial tests EGCG combined with diet, exercise, and cognitive training to slow decline in ApoE4 carriers with early warning signs.
Clinical Trial
May 15, 2026 0
Brain Health
Omega-3 Supplements Show Promise for Preventing Cognitive Decline in At-Risk Older Adults
18-month trial tested omega-3 supplementation in 774 older adults with low DHA/EPA levels and memory concerns to prevent cognitive decline.
Clinical Trial
Mar 28, 2026 1
Brain Health
First Human Trial of Oral D-Peptide Drug Targeting Alzheimer's Toxic Oligomers Completed
Contraloid acetate, an oral all-D-peptide designed to disassemble toxic amyloid-beta oligomers, completed its first-in-human safety trial in 40 healthy volunteers.
Clinical Trial
Jun 12, 2026 0
Brain Health
New Alzheimer's Drug BMS-984923 Completes Safety Testing in 51 Participants
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
Clinical Trial
Mar 28, 2026 1
Brain Health
Caloric Restriction and Omega-3s Show Promise for Brain Health in Cognitive Decline
Large 6-year study tested dietary interventions including caloric restriction and omega-3s in 330 people with mild cognitive impairment.
Clinical Trial
Mar 28, 2026 1
Page 1 of 2Next